Narendra D. Lalwani is COO at Esperion Therapeutics, Inc. (ESPR). They have made 1 open-market trade across 1 company since 2016, most recently 2016-11-01.
CIK 0001615012
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $50K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ESPR | 5,000 | $16K |
Shares reported on the most recent Form 4, priced at the 2016-11-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ESPR | BUY | 2016-11-01 | 2016-11-03 | $9.93 | $50K | +16.2% | +24.0% | +43.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.